Tokyo, Sept 3, 2010 (JCN Newswire) - Eisai Co., Ltd. announced today that it launched Glufast(R) (Chinese brand name: Kuai ru tuo, generic name: mitiglinide calcium hydrate), a rapid-acting insulin secretagogue, in China on September 1. Glufast is a phenylalanine derived rapid-acting insulin secretagogue originally discovered and developed by Kissei Pharmaceutical Co., Ltd.
